Financial & competing interests disclosure
EM Snyder, TP Olson and R Sprissler have significant financial interest in Geneticure Inc., which has developed multigene panels for blood pressure prescribing using pharmacogenetics. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.
No writing assistance was utilized in the production of this manuscript.